Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Its lead product candidate, tebipenem HBr (tebipenem pivoxil ... Read more
Yahoo
Yahoo
Yahoo
Yahoo
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.